These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31467445)

  • 1. Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review.
    Kessels SJM; Carter D; Ellery B; Newton S; Merlin TL
    Genet Med; 2020 Feb; 22(2):258-267. PubMed ID: 31467445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Carrier Frequency of CFTR Gene Mutations in Pregnancies With Echogenic Bowel in Nova Scotia and Prince Edward Island.
    Miller ME; Allen VM; Brock JK
    J Obstet Gynaecol Can; 2018 Jul; 40(7):896-902. PubMed ID: 29503250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cross-Sectional Study of the Marital Attitudes of Pregnant Women at Risk for Cystic Fibrosis and Psychological Impact of Prenatal Screening.
    Popa ZL; Margan MM; Petre I; Bernad E; Stelea L; Chiriac VD; Craina M; Ciuca IM; Bina AM
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
    Modra LJ; Massie RJ; Delatycki MB
    Med J Aust; 2010 Aug; 193(3):157-60. PubMed ID: 20678044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis.
    Bruni T; Mameli M; Pravettoni G; Boniolo G
    Med Health Care Philos; 2012 Aug; 15(3):321-8. PubMed ID: 21863402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing carrier screening for cystic fibrosis outside the clinic: ethical analysis in the light of the personalist view.
    Di Pietro ML; Teleman AA; Gonzalez-Melado FJ; Zace D; Di Raimo FR; Lucidi V; Refolo P
    Clin Ter; 2018; 169(2):e71-e76. PubMed ID: 29595869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier screening for cystic fibrosis: a perinatal perspective.
    Demsey SA
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis.
    Denayer L; Evers-Kiebooms G; De Boeck K; Van den Berghe H
    Am J Med Genet; 1992 Sep; 44(1):104-11. PubMed ID: 1519639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease-causing variants.
    Jeppesen LD; Lildballe DL; Hatt L; Hedegaard J; Singh R; Toft CLF; Schelde P; Pedersen AS; Knudsen M; Vogel I
    Prenat Diagn; 2023 Jan; 43(1):3-13. PubMed ID: 36447355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of a cystic fibrosis carrier testing clinic for couples.
    Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
    Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is testing for cytomegalovirus and cystic fibrosis indicated in members of a nonwhite pregnant population in whom the fetus has an echogenic bowel?
    Aboujaoude R; Alvarez J; Ganesh V; Apuzzio J
    Am J Perinatol; 2006 Jul; 23(5):319-23. PubMed ID: 16799919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of preconceptional and prenatal cystic fibrosis carrier screening: a systematic review.
    Banzi R; Allocati E; Gerardi C; Castellani C; Rissone M; Stracuzzi M; Ferrario L; Foglia E; Mosconi P; Colombo C
    Epidemiol Prev; 2023; 47(4-5):243-256. PubMed ID: 37846447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal genetics: the evolution and future directions of screening and diagnosis.
    Slack C; Lurix K; Lewis S; Lichten L
    J Perinat Neonatal Nurs; 2006; 20(1):93-7. PubMed ID: 16508474
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic implications of fetal echogenic bowel.
    Slotnick RN; Abuhamad AZ
    Lancet; 1996 Jan; 347(8994):85-7. PubMed ID: 8538346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women?
    Mennie ME; Axworthy D; Liston WA; Brock DJ
    Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy.
    Mouawia H; Saker A; Jais JP; Benachi A; Bussières L; Lacour B; Bonnefont JP; Frydman R; Simpson JL; Paterlini-Brechot P
    Reprod Biomed Online; 2012 Nov; 25(5):508-20. PubMed ID: 23000084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based genetic carrier screening for cystic fibrosis in Victoria.
    Archibald AD; Massie J; Smith MJ; Dalton DG; du Sart D; Amor DJ
    Med J Aust; 2014 Mar; 200(4):205-6. PubMed ID: 24580517
    [No Abstract]   [Full Text] [Related]  

  • 19. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for cystic fibrosis using allelic association.
    Ivinson AJ; Read AP; Harris R; Super M; Schwarz M; Clayton Smith J; Elles R
    J Med Genet; 1989 Jul; 26(7):426-30. PubMed ID: 2746614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.